ZS Pharma
ZS Pharma develops and commercializes non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases.
Business Model:
Revenue: $25M
Employees: 51-200
Rankings
Industries / Tags:
Detailed ZS Pharma Information
ZS Pharma was acquired by
AstraZeneca.
The acquisition happend on 2015-11-06.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 1100 Park Pl
City: San Mateo
State: CA
Zip: 94403
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$20M
Raised Total:$123M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
ZS Pharma develops and commercializes non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases.
Contact Phone:
+16504584100
Contact Email:
ZS Pharma went public on 6/19/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/19/2014
IPO Valuation:
$300M
Ticker Symbol:
ZSPH
IPO Price:
$27/share
Amount Raised:
$112M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
